It seems like excessive optimism to base your forecasts on GSK...

It seems like excessive optimism to base your forecasts on GSK producing and selling at capacity during the quarter (whether that capacity is 90m or 190m courses).

You are basing your entire estimate on a couple of comments made during the height of the flu pandemic. GSK has not made a single comment since at least Dec 09 that would suggest it is still producing at max capacity.

Each to their own but you have set yourself up for nothing but disappointment.